Search
1015 results for search term: covid
Category:
Biological and Medicinal Chemistry
,
Working Paper
, Title:
COVID-KOP: Integrating Emerging COVID-19 Data with the ROBOKOP Database
, Authors:
Daniel Korn, Tesia Bobrowski, Michael Li, Yaphet Kebede, Patrick Wang, Phillips Owen, Gaurav Vaidya, Eugene Muratov, Rada Chirkova, Cristopher Bizon, Alexander Tropsha
Extract found to contain search terms
In response to the COVID -19 pandemic, we established COVID -KOP, a new knowledgebase integrating the existing ROBOKOP biomedical knowledge graph with information from recent biomedical literature on COVID -19 annotated in the CORD-19 collection. COVID -KOP can be used effectively to test new hypotheses concerning repurposing of known drugs and clinical drug candidates against COVID -19. COVID669
Downloads
Category:
Analytical Chemistry
,
Working Paper
, Title:
Possible Drug Candidates for COVID-19
, Authors:
Navan Chauhan
Extract found to contain search terms
COVID4,150
Downloads
3
Citations
Category:
Biological and Medicinal Chemistry
,
Working Paper
, Title:
The NIH Lipo-COVID Study: A pilot NMR investigation of lipoprotein subfractions and other metabolites in patients with severe COVID-19.
, Authors:
Rami A. Ballout, Hyesik Kong, Maureen Sampson, James D. Otvos, Andrea Cox, Sean Agbor-Enoh, Alan T. Remaley
Extract found to contain search terms
Patients with severe COVID -19 have been reported to have low levels of total cholesterol, HDL-cholesterol, and LDL-cholesterol, but elevated levels of triglycerides. However, detailed characterization of particle number and size of the different plasma lipoproteins in patients with COVID -19 has yet to be reported. In this pilot investigational study, NMR spectroscopy was used to characterize lipoprotein particle numbers and sizes, as well as various metabolites, in 32 patients with severe COVID183
Downloads
Category:
Biological and Medicinal Chemistry
,
Working Paper
, Title:
Gliptin Repurposing for COVID-19
, Authors:
Matthew Groves, Alexander Domling, Angel Jonathan Ruiz Moreno, Atilio Reyes Romero, Constantinos Neochoritis, Marco Velasco-Velázquez
Extract found to contain search terms
Drug repurposing aims to discover novel indications for already approved 34 drugs.3 The overwhelming advantage of drug repurposing is the much faster clinical approval, due to 35 already extensive knowledge of the physicochemical properties and behavior of the drug in humans. 36 Therefore, many groups have pursued a drug repurposing approach. This has led to several promising 37 drugs which are currently tested for COVID -19 in humans, including Favipiravir, Remdesivir, HIV protease 38 inhibitors, chloroquine or Tozilizumab.4,5 So far, however, none showed more than promising activity 39 based on low numbers of patients per trial. Additionally, a combination of Lopinavir and Ritonavir 40 (Kaletra®) – effective for HIV infection – failed in ~200 severe COVID954
Downloads
3
Citations
Category:
Biological and Medicinal Chemistry
,
Review
, Title:
Fluorine in Medicinal Chemistry: In Perspective to COVID-19
, Authors:
CHENG ZHANG
Extract found to contain search terms
Over two years into the outbreak of COVID -19, the quest for effective and economical drugs has become starkly clear to reduce the risk of progression of coronavirus disease. A number of drugs have been investigated and they can be taken orally at home and be used after exposure to SARS-CoV-2 or at the first sign of COVID -19. Fluorinated oral anti-COVID -19 drugs—including Paxlovid, the first oral tablet for the treatment of COVID -19—is an important subgroup. Fluorine has been widely used in pharmaceuticals market and can lead to improved selectivity indices, increased lipophilicity, greater metabolic stability, and in this case the improved anti-COVID594
Downloads
Category:
Biological and Medicinal Chemistry
,
Working Paper
, Title:
Dose COVID-19 Uncovered a New Feature of Metronidazole Drug?Dose COVID-19 Uncover a New Feature of Metronidazole Drug?
, Authors:
Mohammad Seyedhamzeh, Bahareh Farasati Far, Mehdi Shafiee Ardestani, Shahrzad Javanshir, Fatemeh Aliabadi, Hamed Reyhanfard, Hamidreza Pazoki-Toroudi
Extract found to contain search terms
Studies of coronavirus disease 2019 (COVID1,037
Downloads
Category:
Biological and Medicinal Chemistry
,
Working Paper
, Title:
Data-Driven Drug Repurposing for COVID-19
, Authors:
Raghvendra Mall, Abdurrahman Elbasir, Hossam Al Meer, Sanjay Chawla, Ehsan Ullah
Extract found to contain search terms
Disclaimer: Our models are computational and the drugs suggested should not be taken for treating COVID563
Downloads
1
Citations
Category:
Biological and Medicinal Chemistry
,
Working Paper
, Title:
Repurposing of SARS Inhibitors Against COVID 19
, Authors:
Priyanka Rajbhar, Dikshant Singh, Ruchi Yadav
Extract found to contain search terms
Homology modelling and docking studies has been mainly done to identify the interaction and binding affinity of previous drugs and how they could act as a potential solution to stop the overall spread of the disease in case of pandemic like COVID644
Downloads
1
Citations
Category:
Biological and Medicinal Chemistry
,
Working Paper
, Title:
Text and Network-Mining for COVID-19 Intervention Studies
, Authors:
Aditya Rao, VG Saipradeep, Thomas Joseph, Sujatha Kotte, Naveen Sivadasan, Rajgopal Srinivasan
Extract found to contain search terms
Amongst the novel repurposing drugs predicted, laninamivir and paritaprevir are possible COVID -19 anti-viral drugs while pranlukast was postulated to be a candidate for managing severe respiratory symptoms in COVID902
Downloads
Category:
Biological and Medicinal Chemistry
,
Working Paper
, Title:
Treatment of COVID-19 patients: Justicia adhatoda leaves extract is a strong remedy for COVID-19 – Case report analysis and docking based study
, Authors:
Abhrajit Bag, Arijit Bag
Extract found to contain search terms
Key words: COVID -19, Structure of COVID -19, Infection mechanism of COVID -19, Model drugs for COVID4,394
Downloads
5
Citations